First Author (Year)	Kim MW (2017) [39]
Title	Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia.
Journal	Scandinavian Journal of Clinical & Laboratory Investigation
Reviewer	RL, CG, KH
Study sponsor	Nil
Study type	Retrospective chart review (January–Decemeber 14)
Location	Seoul Korea
Participants Number Male/Female Median age Patient group	125 62.4% male 72 years (59.5–80.0) In-patient adults with a diagnosis of Community Acquired Pneumonia (CAP)
qSOFA criteria	Respiratory rate of 22/min or greater, altered mentation (AVPU), or systolic blood pressure of 100 mmHg or less
Primary outcome Other outcomes	Evaluate the performance of various biomarkers and other clinical risk scales for predicting 28-day mortality in CAP patients who were admitted to the ED, and to compare the performance of these predictors.
Results	28-day mortality AUC 0.81 for qSOFA ≥2
Note